Cargando…

International benchmarking in oesophageal and gastric cancer surgery

BACKGROUND: Benchmarking on an international level might lead to improved outcomes at a national level. The aim of this study was to compare treatment and surgical outcome data from the Swedish National Register for Oesophageal and Gastric Cancer (NREV) and the Dutch Upper Gastrointestinal Cancer Au...

Descripción completa

Detalles Bibliográficos
Autores principales: Busweiler, L. A. D., Jeremiasen, M., Wijnhoven, B. P. L., Lindblad, M., Lundell, L., van de Velde, C. J. H., Tollenaar, R. A. E. M., Wouters, M. W. J. M., van Sandick, J. W., Johansson, J., Dikken, J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354189/
https://www.ncbi.nlm.nih.gov/pubmed/30734017
http://dx.doi.org/10.1002/bjs5.50107
_version_ 1783391136453230592
author Busweiler, L. A. D.
Jeremiasen, M.
Wijnhoven, B. P. L.
Lindblad, M.
Lundell, L.
van de Velde, C. J. H.
Tollenaar, R. A. E. M.
Wouters, M. W. J. M.
van Sandick, J. W.
Johansson, J.
Dikken, J. L.
author_facet Busweiler, L. A. D.
Jeremiasen, M.
Wijnhoven, B. P. L.
Lindblad, M.
Lundell, L.
van de Velde, C. J. H.
Tollenaar, R. A. E. M.
Wouters, M. W. J. M.
van Sandick, J. W.
Johansson, J.
Dikken, J. L.
author_sort Busweiler, L. A. D.
collection PubMed
description BACKGROUND: Benchmarking on an international level might lead to improved outcomes at a national level. The aim of this study was to compare treatment and surgical outcome data from the Swedish National Register for Oesophageal and Gastric Cancer (NREV) and the Dutch Upper Gastrointestinal Cancer Audit (DUCA). METHODS: All patients with primary oesophageal or gastric cancer who underwent a resection and were registered in NREV or DUCA between 2012 and 2014 were included. Differences in 30‐day mortality were analysed using case mix‐adjusted multivariable logistic regression. RESULTS: In total, 4439 patients underwent oesophagectomy (2509 patients) or gastrectomy (1930 patients). Estimated resection rates were comparable. Swedish patients were older but had less advanced disease and less co‐morbidity than Dutch patients. Neoadjuvant treatment rates were lower in Sweden than in the Netherlands, both for patients who underwent oesophagectomy (68·6 versus 90·0 per cent respectively; P < 0·001) and for those having gastrectomy (38·3 versus 56·6 per cent; P < 0·001). In Sweden, transthoracic oesophagectomy was performed in 94·7 per cent of patients, whereas in the Netherlands, a transhiatal approach was undertaken in 35·8 per cent. Higher annual procedural volumes per hospital were observed in the Netherlands. Adjusted 30‐day and/or in‐hospital mortality after gastrectomy was statistically significantly lower in Sweden than in the Netherlands (odds ratio 0·53, 95 per cent c.i. 0·29 to 0·95). CONCLUSION: For oesophageal and gastric cancer, there are differences in patient, tumour and treatment characteristics between Sweden and the Netherlands. Postoperative mortality in patients with gastric cancer was lower in Sweden.
format Online
Article
Text
id pubmed-6354189
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-63541892019-02-07 International benchmarking in oesophageal and gastric cancer surgery Busweiler, L. A. D. Jeremiasen, M. Wijnhoven, B. P. L. Lindblad, M. Lundell, L. van de Velde, C. J. H. Tollenaar, R. A. E. M. Wouters, M. W. J. M. van Sandick, J. W. Johansson, J. Dikken, J. L. BJS Open Original Articles BACKGROUND: Benchmarking on an international level might lead to improved outcomes at a national level. The aim of this study was to compare treatment and surgical outcome data from the Swedish National Register for Oesophageal and Gastric Cancer (NREV) and the Dutch Upper Gastrointestinal Cancer Audit (DUCA). METHODS: All patients with primary oesophageal or gastric cancer who underwent a resection and were registered in NREV or DUCA between 2012 and 2014 were included. Differences in 30‐day mortality were analysed using case mix‐adjusted multivariable logistic regression. RESULTS: In total, 4439 patients underwent oesophagectomy (2509 patients) or gastrectomy (1930 patients). Estimated resection rates were comparable. Swedish patients were older but had less advanced disease and less co‐morbidity than Dutch patients. Neoadjuvant treatment rates were lower in Sweden than in the Netherlands, both for patients who underwent oesophagectomy (68·6 versus 90·0 per cent respectively; P < 0·001) and for those having gastrectomy (38·3 versus 56·6 per cent; P < 0·001). In Sweden, transthoracic oesophagectomy was performed in 94·7 per cent of patients, whereas in the Netherlands, a transhiatal approach was undertaken in 35·8 per cent. Higher annual procedural volumes per hospital were observed in the Netherlands. Adjusted 30‐day and/or in‐hospital mortality after gastrectomy was statistically significantly lower in Sweden than in the Netherlands (odds ratio 0·53, 95 per cent c.i. 0·29 to 0·95). CONCLUSION: For oesophageal and gastric cancer, there are differences in patient, tumour and treatment characteristics between Sweden and the Netherlands. Postoperative mortality in patients with gastric cancer was lower in Sweden. John Wiley & Sons, Ltd 2018-10-19 /pmc/articles/PMC6354189/ /pubmed/30734017 http://dx.doi.org/10.1002/bjs5.50107 Text en © 2018 The Authors. BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Busweiler, L. A. D.
Jeremiasen, M.
Wijnhoven, B. P. L.
Lindblad, M.
Lundell, L.
van de Velde, C. J. H.
Tollenaar, R. A. E. M.
Wouters, M. W. J. M.
van Sandick, J. W.
Johansson, J.
Dikken, J. L.
International benchmarking in oesophageal and gastric cancer surgery
title International benchmarking in oesophageal and gastric cancer surgery
title_full International benchmarking in oesophageal and gastric cancer surgery
title_fullStr International benchmarking in oesophageal and gastric cancer surgery
title_full_unstemmed International benchmarking in oesophageal and gastric cancer surgery
title_short International benchmarking in oesophageal and gastric cancer surgery
title_sort international benchmarking in oesophageal and gastric cancer surgery
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354189/
https://www.ncbi.nlm.nih.gov/pubmed/30734017
http://dx.doi.org/10.1002/bjs5.50107
work_keys_str_mv AT busweilerlad internationalbenchmarkinginoesophagealandgastriccancersurgery
AT jeremiasenm internationalbenchmarkinginoesophagealandgastriccancersurgery
AT wijnhovenbpl internationalbenchmarkinginoesophagealandgastriccancersurgery
AT lindbladm internationalbenchmarkinginoesophagealandgastriccancersurgery
AT lundelll internationalbenchmarkinginoesophagealandgastriccancersurgery
AT vandeveldecjh internationalbenchmarkinginoesophagealandgastriccancersurgery
AT tollenaarraem internationalbenchmarkinginoesophagealandgastriccancersurgery
AT woutersmwjm internationalbenchmarkinginoesophagealandgastriccancersurgery
AT vansandickjw internationalbenchmarkinginoesophagealandgastriccancersurgery
AT johanssonj internationalbenchmarkinginoesophagealandgastriccancersurgery
AT dikkenjl internationalbenchmarkinginoesophagealandgastriccancersurgery